Breast Cancer
Phase II Randomized Trial of Neoadjuvant Trastuzumab and/or Lapatinib plus Chemotherapy (Sequential FEC75 and Paclitaxel) in Women with ErbB2 (HER2) Overexpressing Invasive Breast Cancer
Trial ID: 05074
Contact: Maria W Crockett
Phone: (281)863-4668
Learn More about this trial.
go back | new search